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Disentangling the roles of 
cholesterol and CD59 in 
intermedilysin pore formation
Courtney M. Boyd1, Edward S. Parsons2,3, Richard A. G. Smith4, John M. Seddon2, Oscar Ces2 
& Doryen Bubeck1
The plasma membrane provides an essential barrier, shielding a cell from the pressures of its external 
environment. Pore-forming proteins, deployed by both hosts and pathogens alike, breach this barrier to 
lyse target cells. Intermedilysin is a cholesterol-dependent cytolysin that requires the human immune 
receptor CD59, in addition to cholesterol, to form giant β-barrel pores in host membranes. Here we 
integrate biochemical assays with electron microscopy and atomic force microscopy to distinguish the 
roles of these two receptors in mediating structural transitions of pore formation. CD59 is required for 
the specific coordination of intermedilysin (ILY) monomers and for triggering collapse of an oligomeric 
prepore. Movement of Domain 2 with respect to Domain 3 of ILY is essential for forming a late prepore 
intermediate that releases CD59, while the role of cholesterol may be limited to insertion of the 
transmembrane segments. Together these data define a structural timeline for ILY pore formation and 
suggest a mechanism that is relevant to understanding other pore-forming toxins that also require 
CD59.
Pore-forming proteins oligomerize on target cell membranes to punch holes in lipid bilayers. Cytotoxic pores 
can be used for either attack or defense and are prolific throughout all kingdoms of life1. Pore-forming toxins 
represent the largest group of virulence factors secreted by pathogenic bacteria2. Produced by both Gram-positive 
and Gram-negative bacteria3, cholesterol-dependent cytolysins (CDCs) comprise a subset of toxins that require 
cholesterol to form giant β -barrel pores in lipid bilayers4. Despite variations in size and stoichiometry that make 
up mature pore complexes, the general mechanism of pore formation is highly conserved. The process is initiated 
when soluble toxin monomers bind to their target membrane5. Membrane-binding allosterically activates the 
monomer and promotes oligomerization6. Finally, the complex undergoes dramatic structural rearrangements to 
form the transmembrane pore7.
Structural analyses of soluble CDC monomers have defined a highly conserved modular arrangement of 
four domains8–10. Domains 1 and 3 (D1 and D3) make up the Membrane Attack Complex/Perforin-like Fold 
(MACPF), a kinked ‘L’-shaped motif formed by a central β -sheet. Upon pore formation, α -helical bundles within 
D3 unfurl and contribute two β -hairpins to the transmembrane pore11,12. In contrast, Domain 4 (D4) governs 
membrane-binding and cholesterol recognition13. In the soluble toxin, transmembrane segments in D3 are 
located far above D4 membrane-interacting residues (~30–40 Å). Therefore, to traverse the bilayer CDCs must 
undergo a vertical collapse and structural rearrangement involving Domain 2 (D2), an elongated and twisted 
β -sheet14.
For many CDCs, cholesterol-binding is sufficient to trigger conformational changes in the toxin during pore 
formation; however a sub-class, for which intermedilysin (ILY) is an archetypal member, also require the immune 
receptor CD5915. ILY is secreted by Streptococcus intermedius and is the major virulence factor for the bacterium 
associated with the formation of brain and liver abscesses in human hosts16. ILY’s specificity for human cells is 
conferred through its interaction with CD59, a small glycophosphatidyl-inositol (GPI)-anchored protein that 
inhibits pore formation of the complement membrane attack complex17. Mutational analyses and structural stud-
ies of the ILY-CD59 complex have demonstrated that although the CD59-binding site is located in D4, residues 
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that make up the interface are different from those that interact with cholesterol in the lipid bilayer18,19. While it 
is known that both cholesterol and CD59 must be present for ILY to permeate the target cell, the precise role of 
each receptor remains unclear.
Here we use model membrane systems decorated with CD59 and conformationally-locked ILY variants to 
disentangle structural transitions triggered by cholesterol and human CD59. Specifically, we investigate the roles 
of each receptor in ILY oligomerization, vertical collapse of the prepore complex, and membrane lysis. Adopting 
a dual biochemical and biophysical approach, we find that CD59 is required for coordinating ILY monomers 
into an oligomeric prepore that can collapse towards the membrane. Formation of an SDS-resistant late prepore 
depends on structural transitions enabled by a movement between D2 and D3. Our data suggest that CD59 is 
released from the late-prepore, and that cholesterol triggers the final stages of membrane insertion.
Results
ILY requires both cholesterol and CD59 to form pores in lipid bilayers. To distinguish the roles of these two recep-
tors in structural transitions of pore formation, we developed a versatile model membrane system whose lipid 
composition could be altered and that incorporated soluble CD59 modified to contain a myristolated lysine-rich 
“cytotopic” peptide (cytoCD59)20. This system was adapted to a variety of model membranes including liposomes, 
monolayers and supported lipid bilayers for use in biochemical assays and imaging by electron microscopy (EM) 
as well as atomic force microscopy (AFM) techniques.
ILY oligomerization. CD59 is known to induce the formation of sodium dodecyl sulphate (SDS)-resistant 
ILY oligomeric pores on the surface of human cells21. To verify that our model membrane system could also 
support the formation of SDS-resistant oligomers, consistent with late-prepore and pore states of ILY, we used 
Agarose Gel Electrophoresis (AGE) followed by western blot analysis (Fig. 1a). In the absence of membranes, 
neither ILY alone nor ILY with soluble CD59 could form oligomers. In addition, ILY remained monomeric 
when incubated with liposomes lacking both cholesterol and cytoCD59. Furthermore, SDS-resistant oligomers 
formed on membranes containing both cholesterol and cytoCD59. However, unexpectedly oligomers were also 
observed on liposomes when either of these two components was lacking. Electron microscopy of negatively 
stained monolayers was used to visualize ILY oligomers (Fig. 1b–d). Independent of cholesterol in the lipid 
composition, all monolayers containing cytoCD59 possessed regular ring and arc-like geometries (Fig. 1b–c and 
Supplementary Table S1), consistent with previously reported CDC pores7. On cholesterol-containing monolay-
ers lacking cytoCD59, ILY was mostly found to form nonspecific aggregates. However, densely packed irregular 
rings were also seen in some areas of the monolayers where local concentrations of cholesterol may have been 
Figure 1. CD59 coordinates a specific geometry for ILY oligomeric prepores. (a) Wildtype ILY was 
incubated with CD59-decorated liposomes; monomers and oligomers were separated by SDS-AGE and 
transferred to nitrocellulose. His-tagged toxin was detected using western blot analysis. The + or − denoted at 
the top of the panel indicates whether the toxin was incubated with or without cholesterol-containing liposomes 
(Chol) or cytoCD59. ILY only contains neither liposomes nor CD59. ILY and CD59 refer to the incubation of 
soluble proteins in the absence of membranes. Molecular weight marker is in the far left lane. (b–d) Electron 
micrographs of negatively stained ILY oligomers formed on lipid monolayers. (b) ILY-cytoCD59 complexes on 
cholesterol containing monolayers. (c) ILY-cytoCD59 complexes formed on cholesterol-lacking monolayers. 
(d) ILY oligomers on cholesterol-rich monolayers formed in the absence of CD59. Two types of oligomers are 
shown in left and right panels. Scale bar, 50 nm.
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higher (Fig. 1d and Supplementary Table S1). Therefore, our biochemical and electron microscopy data together 
suggest that although ILY can form oligomers on cholesterol containing membranes, CD59 is involved in setting 
the specific template geometry that governs the diameter of oligomeric ILY rings.
CD59 is responsible for collapse of the ILY prepore. Upon pore formation, CDC oligomers undergo 
a dramatic vertical collapse bringing residues in D3 that penetrate the lipid bilayer close to their target mem-
brane14. To test if ILY oligomers formed in the absence of cholesterol undergo a vertical collapse, we imaged com-
plexes using AFM on supported lipid bilayers (Fig. 2). Previous studies have shown that forming large plaques 
of mobile prepores slow their diffusion and enable AFM imaging7. As such, cytoCD59 was used to densely coat 
the membrane and restrict movement of ILY prepores. Moreover, baseline measurements read 2 nm above the 
membrane surface, consistent with the dimensions of CD59 (Fig. 2a,b). An early prepore intermediate of ILY 
captured with a disulfide-locked mutant (ILYTI) was used to assess the initial height of the complex. This mutant 
is unable to form SDS resistant oligomers or lyse cells; however, activity is restored under reducing conditions21. 
The cytoCD59-bound ILYTI prepore forms large, non-specific aggregates on monolayers (Supplementary Fig. S1) 
and supported lipid bilayers (Fig. 2c). The complex measures approximately 8 nm above the baseline, (10 nm 
above the membrane surface) (Fig. 2a and c), consistent with the ILYTI-CD59 crystal structure19 and in agreement 
with other CDC prepore structures7,14. In contrast, wild-type ILY oligomers that bound cytoCD59-containing 
bilayers were between 5 and 6 nm above the baseline (7–8 nm above the membrane), independent of choles-
terol in the membrane composition (Fig. 2d,e and Supplementary Fig. S2). To test if cholesterol alone could 
Figure 2. CD59 triggers a collapse of the ILY prepore. (a) Schematic of ILY structural transitions. ILY colored 
by domains (D1, blue; D2, yellow; D3, green; D4, red) and CD59 in purple. Top panel denotes the ILYTI-CD59 
crystal structure (PDB ID: 4BIK)19. Bottom panel illustrates a model for the complex after collapse. (b–e) AFM 
images (top panel) and corresponding height data (bottom panel) for ILY-CD59 complexes on supported lipid 
bilayers. Height data is plotted as a histogram of the z measurements for each pixel in the image, with the inset 
showing a cross-section of the area highlighted by the blue dotted line. All bilayers contain cholesterol unless 
otherwise indicated by –Chol. Color scale, 15 nm. (b) cytoCD59 on a supported lipid bilayer. (c) ILYTI bound to a 
cytoCD59-decorated bilayer. (d) wildtype ILY bound a to cytoCD59-decorated bilayer. (e) Wildtype ILY bound to 
a cytoCD59-decorated bilayer lacking cholesterol.
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trigger the vertical collapse of oligomers, non-specific aggregates and clustered, irregular rings formed in the 
absence of cytoCD59, similar to those observed on negatively stained monolayers, (Fig. 1d) were measured by 
AFM (Supplementary Fig. S3). These irregular oligomers measured between 10 and 15 nm above the membrane 
surface. Together, these data suggest the structural transitions that result in a vertical collapse of ILY are mediated 
by CD59 and not cholesterol.
CD59 release from ILY prepore states. ILY binds CD59 during the early stages of pore formation; 
however, the receptor is released from the final transmembrane complex21. To define the temporal relation-
ship between oligomerization, vertical collapse, and CD59-release, we used a flotation assay to assess ILY 
co-localization with CD59-decorated liposomes (Fig. 3a). Rhodamine-labeled phosphatidylethanolamine, 
included in the lipid composition, was used to track membrane-containing fractions across a ficoll density gradi-
ent. Nearly all cytoCD59 present in the reaction associated with liposomes (Supplementary Fig. S4); any remaining 
soluble CD59 is unable to cause oligomerization (Fig. 1a). ILYTI, a variant unable to undergo a vertical collapse 
(Fig. 2c), was incubated with cytoCD59-decorated liposomes and subjected to density centrifugation (Fig. 3b). 
Western blot analysis of AGE gel fractions showed that ILYTI prepore complexes were SDS-sensitive, in agree-
ment with previous studies21, and that the majority of ILYTI colocalized with lipid-containing fractions. Some 
ILYTI remained at the bottom of the gradient, consistent with a dynamic binding interaction of transient early 
prepore complexes22. To test for the release of late prepores, cytoCD59 decorated liposomes that lacked cholesterol 
were incubated with wild type ILY (Fig. 3c). Top and bottom fractions of the gradient contained SDS-resistant 
oligomers, indicating that CD59 can release a late-prepore conformation. As soluble proteins do not spontane-
ously oligomerize even at high concentrations (Fig. 1a), non-membrane associated oligomers must be formed 
on the bilayer prior to release. The presence of oligomeric ring structures on and off liposomes was confirmed 
by 2D electron cryo-microscopy (cryo-EM) (Fig. 3d). While oligomers released from the membrane clearly dis-
sociate from CD59, those that remain could either be still bound to CD59 or interact with membranes in a 
CD59-independent manner. It is possible that trans-membrane segment (TMS) regions, unrestricted in wildtype 
ILY, could unfurl and interact with the surface of the bilayer in a transient manner whereby the affinity of the 
interaction is insufficient to maintain membrane contact. Monomeric ILY was also observed in both regions 
of the gradient. These data suggest that oligomer formation maybe less efficient in the absence of cholesterol. 
As pores generate large holes in liposomes, resulting in vesicles filled with ficoll, wildtype pore conditions were 
unable to be characterized by flotation. However, previous cryo-EM studies of wildtype pores demonstrate that 
oligomers remain membrane bound19.
To probe which residues of ILY are essential for CD59 release, a novel prepore state was captured with a 
disulfide-locked mutant (ILYIG) predicted to restrict movement between D2 and D3 (Figs 4 and 5a). Specifically, 
it locks the base of transmembrane segment 1 (TMS1) of D3 with the adjacent β -strand of D2. Liposome flotation 
assays of ILYIG confirm the association of cytoCD59-decorated liposomes with an SDS-sensitive prepore (Fig. 4a). 
Figure 3. CD59 releases an ILY late-prepore independent of cholesterol. (a) Schematic illustrating the 
liposome flotation assay. Liposomes decorated with cytoCD59 were incubated with ILY and subjected to density 
centrifugation. Monomeric and oligomeric forms of the toxin in each fraction were separated by SDS-AGE 
and detected by western blot analysis. Samples containing cholesterol-rich liposomes and the ILYTI variant 
are shown in (b), while those in (c) contain wildtype ILY prepores formed on liposomes lacking cholesterol. 
Fractions from a single gradient span two gels (left and right). Directionality of fractionation is indicated by 
Top and Bottom above gels. The first lane in each gel contains molecular weight markers. (d) Cryo-electron 
micrograph of the sample analyzed in panel c showing ILY oligomeric prepores on liposomes (white arrows) 
and those released from the membrane (red arrows). Scale bar, 50 nm.
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Intriguingly, little to no monomeric ILY was observed at the bottom of the gradient. 2D cryo-EM images of ILYIG 
on cytoCD59–decorated liposomes reveal arc and ring structures on the membrane surface (Fig. 4b). Together 
these data demonstrate that movement between D3 and D2 is essential for formation of a late prepore interme-
diate and the release of CD59.
Probing the trigger for membrane penetration. To gain insight into the molecular mechanism by 
which the TMSs of ILY insert into the lipid bilayer, we tested the role of cholesterol and of ILY domain mobility 
using disulfide-locked mutants in a fluorescence-based liposome lysis assay (Fig. 5 and Supplementary Table S2). 
Fluorescence intensity of calcein released from liposomes upon lysis, relative to the total dye released upon deter-
gent solublization, was used to determine the extent of pore formation. While lysis was observed when wild-
type ILY was incubated with cholesterol-containing liposomes decorated with cytoCD59, the absence of either 
component abolished activity. These data, combined with evidence that CD59 can induce both oligomerization 
and collapse of a late prepore state, suggest that the role of cholesterol maybe restricted to membrane inser-
tion. Furthermore, lytic activity was abrogated for the novel early prepore state captured by the ILYIG mutant. 
Alkylation of ILYIG irreversibly reduced its disulfide bond and rescued its activity, confirming that impaired func-
tionality of the mutant is specifically due to the disulfide bond.
Discussion
CDC pore formation is a complex and co-operative processes involving membrane recognition, oligomerization 
of monomers, vertical collapse of a prepore, and penetration of the lipid bilayer. For CDCs such as ILY, that 
require human CD59 in addition to cholesterol to form pores, structural transitions triggered by each component 
remain less clear. We establish here that CD59 is required for the specific coordination of an ILY oligomer and 
for the vertical collapse of a late prepore state. We demonstrate that movement of D2 relative to D3 is essential 
for generating an SDS-resistant late prepore. Furthermore, our results place CD59 release along a timeline of 
Figure 4. ILYIG forms an SDS-sensitive early prepore that remains membrane-bound. (a) ILYIG was 
incubated with cytoCD59-decorated, cholesterol-containing liposomes and subjected to flotation through ficoll. 
Toxin within gradient fractions was analyzed by SDS-AGE and western blot. Fractions span two gels with 
direction of fractionation indicated by Top and Bottom. Molecular weight markers are in the first lane of each 
gel. (b) Cryo-electron micrograph of the sample analyzed in panel a showing SDS-sensitive oligomeric prepores 
on liposomes (white arrows). Scale bar, 50 nm.
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structural transitions for ILY pore formation and reveal that the role of cholesterol may be restricted to the final 
stages of membrane insertion (Fig. 5c).
Membrane targeting by a receptor is allosterically coupled to oligomerization of CDC monomers. For 
non-CD59-binding CDCs, the interaction of cholesterol with residues in D4 activates membrane-bound mono-
mers and triggers oligomerization within D1 and D323. Disengagement of the β -5 strand of the central MACPF 
renders its 4th β -strand accessible to an adjacent monomer24. Cholesterol-binding and formation of a stable 
dimeric intermediate lowers the energy barrier of this normal thermal fluctuation and enables the π -stacking of 
two key aromatic residues on respective strands to form an SDS-resistant oligomeric prepore24. The crystal struc-
ture of soluble CD59 in complex with an ILY variant unable to release β -5 from β -4 (ILYTI) showed that CD59 
coordinates two ILY monomers19, reminiscent of the stable dimer formed in the non-CD59-binding cytolysins25. 
In contrast to studies on cells13, we observe oligomerization in the absence of CD59 on cholesterol-containing 
liposomes and lipid monolayers. However, oligomers on monolayers differ from the regular ring and arc-like 
geometries observed when CD59 is present. Differences observed between model membranes and cells may 
reflect variations in experimental procedures or the distribution of cholesterol found with these membranes. It 
is known that that the percentage of cholesterol in the lipid composition and the lipid environment itself, which 
influences the accessibility of cholesterol’s head group, play key roles in the rate of allosteric activation26.
CD59-binding of ILY monomers primes the toxin for integration into an oligomeric prepore. Oligomerization 
of activated CDC monomers is thought to increase the avidity of the interaction27. The lack of unbound mon-
omers observed for the ILYIG prepore-locked mutant further supports this hypothesis. ILYIG, free to rotate its 
β -5 strand, oligomerizes through the edge-on β -sheet extension of the MACPF domain. However this variant, 
restricted in its mobility of D2 relative to D3, is unable to complete the transition to an SDS-resistant late prepore.
Membrane binding, mediated by cholesterol or CD59, orients CDC monomers nearly perpendicular to the 
lipid bilayer7,19,28. As a result, the TMSs within D3 are suspended above the target membrane. A vertical collapse 
of the prepore is necessary to enable membrane penetration of the newly formed hairpins. Here we show that 
CD59-binding, rather than cholesterol, triggers structural transitions that enable vertical collapse of a prepore.
Figure 5. Lytic activity of ILY variants. (a) ILY crystal structure (PDB ID: 1S3R)9 with domains colored as 
in Fig. 2. Residues mutated in ILY variants shown as spheres. (b) ILY variants were incubated with calcein-
containing liposomes decorated with cytoCD59, unless otherwise indicated by –cytoCD59. All liposomes contain 
cholesterol unless otherwise indicated by –Cholesterol. Fluorescence measurements, expressed as a percent total 
lysis, were normalized against background and detergent burst vesicles. Error bars indicate standard deviations 
across three independent experiments. (c) Schematic illustrating the temporal roles of CD59 and cholesterol 
in ILY pore formation. ILY and CD59 are represented as space-filled models from the crystal structure of the 
complex (PDB ID: 4BIK). ILY D3 is in lilac; the remainder of the structure is in blue; CD59 is green. Soluble 
ILY is targeted to cholesterol-containing membranes (red sphere), whereby CD59 sets a specific geometry that 
defines the diameter of an oligomeric ILY prepore (blue 3D barrel). CD59 triggers the vertical collapse of this 
prepore, enabling the transmembrane segments of D3 (lilac) to approach the bilayer. CD59 is released from an 
SDS-resistant late prepore prior to membrane insertion, while cholesterol is required for the final membrane 
perforation step.
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In summary our findings provide important mechanistic insight into how CD59 and cholesterol coordinate 
structural transitions of ILY pore formation. Our experiments allow us to understand the temporal relationship of 
each receptor in forming prepore and pore states. As ILY is an archetypal member of a CDC subset that requires 
human CD59 for lysis, these data may represent a general molecular mechanism of pore formation for other 
CD59-binding CDCs.
Methods
Expression and purification of CD59 and ILY variants. The extracellular domain of CD59 with an 
additional C-terminal cysteine residue was expressed in E.coli and purified from inclusion bodies as described 
previously29. The cytotopic variant of CD59 used to decorate liposomes, monolayers and supported lipid 
bilayers was generated using the cytotopic modification reagent bis-myristoyl lysyl SSKKSPSKKDDKKPGD 
(S-2-thiopyridyl)-cysteine acid (APT3146, Cambridge Research Biochemicals) and purified by hydrophobic 
interaction chromatography and ammonium sulfate precipitation, as previously described19. An ily gene lack-
ing cysteine residues (referred to as wildtype ILY) and disulfide-locked ily mutants containing the substitutions 
T346C and I361C (ILYTI) and I104C and G244C (ILYIG) were expressed in BL21 or Shuffle T7 E. coli cells (New 
England Biolabs) using pTrcHisA vectors. Pairs of residues that could potentially form disulfide bonds were iden-
tified using SSBOND30. Mutations were introduced using the Quikchange method (Strategene) and confirmed by 
DNA sequencing. Lack of free sulfhydryl groups from unpaired cysteines was verified using the Thiol and Sulfide 
Quantitation Kit (Molecular Probes) (Supplementary Fig. S5a). Production of the chromophore p-nitroaniline 
was measured on a Jenway 7300 spectrophotometer at an absorbance 410 nm. Wildtype ILY and ILYTI were gen-
erous gifts from R. Tweten.
Cells were grown to OD600 0.8 at 37 °C and expression was induced with 0.5 mM IPTG overnight at 18 °C. 
Cultures were pelleted and lysed by sonication in Buffer A (200 mM NaCl, 20 mM Tris-HCl, pH 7.5) containing 
cOmplete Protease Inhibitors (Roche) and DNAseI (Sigma). His-tagged proteins were bound to cobalt-chelated 
TALON beads (Clontech), washed with 10 mM imidazole, and eluted in steps of 100 and 500 mM imidazole in 
Buffer A. Further purification was carried out using size exclusion chromatography in Buffer A on a Superdex 200 
10/300 column (GE Healthcare) (Fig. S5b). Purity was assessed by sodium dodecyl sulphide – polyacrylamide gel 
electrophoresis (SDS-PAGE); proteins detected with Quick Coomassie Stain (Generon).
Reduction and Alkylation of Disulphide-locked Mutants. ILYIG was irreversibly reduced and alky-
lated at room temperature using the ProteoPrep® Reduction and Alkylation Kit (Sigma). Briefly, purified protein 
was exchanged into Buffer A at pH 8.5 and was concentrated to 5 mg/ml. Incubation of the protein with 5 mM 
tributylphosphine (TBP) for 30 minutes reduced the disulfide bond. Subsequent alkylation was performed by 
reaction with 15 mM iodoacetamide (IAA) for 1 hour. Excess IAA was quenched with 2.5% (v/v) TBP for 15 min-
utes. Alkylated protein was spun for 5 minutes at 20,000× g, followed by buffer exchange into Buffer A at pH 7.5.
Liposome Preparation. 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) (Avanti Polar Lipids), 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Anatrace), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE) (Avanti Polar Lipids) and cholesterol (Sigma) were dissolved in chloroform and mixed (3:2:3:2 w/w 
ratio). The lipid mix was dried under nitrogen gas and rehydrated in Buffer A. Liposomes were extruded through 
a 100 nm polycarbonate membrane (Whatman) to create a monodisperse unilamellar liposome population.
SDS-AGE and Western Blot Analysis. ILY (0.85 μ M) was incubated with or without liposomes (0.29 mg/ml) 
and with or without cytoCD59 (0.85 μ M) for 1 hour at 37 °C. Samples were analyzed by SDS-AGE using a 2% (w/v) 
gel (100 V, 1 hour). The proteins were transferred to a nitrocellulose paper using a TE77 Semi-dry transfer unit 
(Hoefer) at 70 mA for 2 hours at 4 °C. His-tagged ILY was detected using a Penta-His antibody (Qiagen), followed 
by a Anti-Mouse IgG -Alkaline Phosphatase (Sigma). Band visualization was carried out using Sigma Fast BCIP/
NBT tablets (Sigma).
Liposome Flotation Assay. Liposomes were tracked by the incorporation of a phosphatidylethanolamine 
with lissamine rhodamine B-labeled head groups (Avanti Polar Lipids) at a final concentration of 0.1% (w/w) into 
the lipid mixture. Extruded liposomes at a concentration of 1.5 mg/ml were incubated with cytoCD59 and ILY var-
iants at a molar ratio of 1:1 (4.4 μ M) for 1 hour at 37 °C. Samples were mixed with 40% ficoll in Buffer A, resulting 
in a final ficoll concentration of 20% (w/v). A 10% (w/v) ficoll solution was layered on top, followed by Buffer A 
alone, creating a step gradient. Gradients were centrifuged using a TLA 120.1 rotor in an OptimaTM Max bench 
top Ultracentrifuge (Beckman Coulter) at 95, 000 rpm, 4 °C for 1 hour. Gradients were fractionated and analyzed 
by SDS-AGE and western blotting.
Fluorescence-Based Liposome Lysis Assay. Lipid films were rehydrated in Buffer A containing 50 mM 
calcein. Excess calcein was separated from liposomes by gel filtration (Sephadex G-50 beads (Sigma) equilibrated 
in Buffer A with 500 mM sucrose). Fluorescence intensity was measured using a Varian Cary Eclipse Fluorescence 
Spectrophotometer (Agilent Technologies) with excitation and emission wavelengths of 490 nm and 520 nm, 
respectively and a 5 nm slit width. The spectrophotometer was operated in kinetics mode and readings were 
recorded every 30 seconds. cytoCD59 (0.5 μ M) was incubated with 190 μ l of fluorescently-labeled liposomes and 
the average background fluorescence intensity was measured for 10 minutes. Subsequently, ILY variants (0.5 μ M) 
were added, incubated for 1 hour at 37 °C, and fluorescence was measured for an additional hour. Liposomes were 
burst by the addition of 0.2 M C12E8 detergent (Sigma) and the maximum fluorescence per reaction was measured 
for a further 10 minutes. Fluorescence measurements were normalized to the background and detergent readings 
for each reaction.
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Preparation and Negative Staining of Lipid Monolayers. Monolayers were assembled in a Teflon 
plate containing wells. ILY and cytoCD59 were incubated at 37 °C in Buffer A and overlaid with 2 μ l of chloro-
form solution containing 1 mg/ml lipid. For the lipid composition DOPC:cholesterol:DOPS (5:4:1 w/w ratio), 
ILY was mixed with cytoCD59 in an equimolar amount (0.169 μ M) for 30 minutes. For samples lacking cytoCD59, 
ILY (0.127 μ Μ ) was incubated with lipids for 1 hour. Monolayers lacking cholesterol (DOPC:DOPS, 9:1 w/w 
ratio), were incubated with equimolar ILY and cytoCD59 (0.169 μ M) for 5 minutes. Copper grids with a continu-
ous carbon film (Electron Microscopy Sciences) were applied to the top of wells. The plate was sealed in a petri 
dish containing tissue soaked in Buffer A. Grids were removed and samples negatively stained with 2% (w/v) 
uranyl acetate. Monolayers containing cholesterol were imaged on a Tecnai 12 (LaB6 filament) at 120 kV with a 
magnification of 30, 000× (4.48 Å/pixel) or 52,000× (2.6 Å/pixel). Images were acquired using a 2 k × 2 k CCD 
camera (F216, TVIPS). Monolayers lacking cholesterol were imaged on a Tecnai G2 Spirit BioTWIN (Tungsten 
filament) at 120 kV with magnification of 52, 000× (4.35 Å/pixel). Images were acquired using a 2 k × 2 k Eagle 
CCD camera (FEI).
Cryo-Electron Microscopy. Equimolar ILY and CD59 (2.2 μ M) were incubated with 0.75 mg/ml liposomes 
for 1 hour at 37 °C. Samples (2.5 μ l) were applied to glow discharged Quantifoil R2/2 holey carbon grids and 
plunge frozen in liquid ethane cooled to liquid nitrogen temperature using a Mark III vitrobot (FEI). Images were 
acquired on a Philips CM200 (FEG) microscope, 4 k × 4 k TemCam-F415MP CCD camera at 50, 000× magnifi-
cation (1.76 Å/pixel) under low dose conditions. The defocus range used was 2–4 μ m under focus.
Atomic Force Microscopy. Supported lipid bilayers of DOPC: cholesterol:DOPS (5:4:1 molar ratio) and 
DOPC:DOPS (9:1 molar ratio) were prepared via the vesicle fusion method31. Briefly, a dried lipid film was rehy-
drated in Buffer A and vortexed to generate a liposome suspension. The resulting suspension was sonicated to 
form small unilamellar vesicles and incubated upon freshly cleaved mica in the presence of 5 mM calcium chlo-
ride for 20 minutes at room temperature. Supported lipid bilayers were rinsed with Buffer A to remove excess 
vesicles from the supernatant. Equimolar ILY:CD59 (0.17 μ M) was added to supported bilayers and incubated at 
37 °C. Measurements were recorded at room temperature on a MultiMode IV (Bruker) operated in tapping mode 
at a resonance frequency of 7–9 kHz, using PNP-TR and BioTool tips (Nanosensors) and with an ‘E’ scanner. 
Lines were recorded at 1 Hz and image analysis was carried out using Nanoscope Analysis 1.5 (Bruker).
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